The metabolic syndrome and stroke -: Potential treatment approaches

被引:63
作者
Arenillas, Juan F.
Moro, Maria A.
Davalos, Antoni
机构
[1] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, Dept Neurosci, Stroke Unit, Badalona 08916, Spain
[2] Univ Complutense, Sch Med, Dept Pharmacol, E-28040 Madrid, Spain
关键词
D O I
10.1161/STROKEAHA.106.480004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:2196 / 2203
页数:8
相关论文
共 81 条
[71]   Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study [J].
Rutter, MK ;
Meigs, JB ;
Sullivan, LM ;
D'Agostino, RB ;
Wilson, PW .
DIABETES, 2005, 54 (11) :3252-3257
[72]   A peroxisome proliferator-activated receptor-γ agonist reduces infarct size in transient but not in permanent ischemia [J].
Shimazu, T ;
Inoue, I ;
Araki, N ;
Asano, Y ;
Sawada, M ;
Furuya, D ;
Nagoya, H ;
Greenberg, JH .
STROKE, 2005, 36 (02) :353-359
[73]   Abdominal obesity and risk of ischemic stroke - The Northern Manhattan Stroke Study [J].
Suk, SH ;
Sacco, RL ;
Boden-Albala, B ;
Cheun, JF ;
Pittman, JG ;
Elkind, MS ;
Paik, MC .
STROKE, 2003, 34 (07) :1586-1592
[74]   Peroxisome proliferator-activated receptor-γ ligands reduce inflammation and infarction size in transient focal ischemia [J].
Sundararajan, S ;
Gamboa, JL ;
Victor, NA ;
Wanderi, EW ;
Lust, WD ;
Landreth, GE .
NEUROSCIENCE, 2005, 130 (03) :685-696
[75]   Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus [J].
Wannamethee, SG ;
Shaper, AG ;
Lennon, L ;
Morris, RW .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (22) :2644-2650
[76]   Peroxisome proliferator-activated receptor γ and metabolic disease [J].
Willson, TM ;
Lambert, MH ;
Kliewer, SA .
ANNUAL REVIEW OF BIOCHEMISTRY, 2001, 70 :341-367
[77]   Cardiovascular risk factors emerge after artificial selection for low aerobic capacity [J].
Wisloff, U ;
Najjar, SM ;
Ellingsen, O ;
Haram, PM ;
Swoap, S ;
Al-Share, Q ;
Fernström, M ;
Rezaei, K ;
Lee, SJ ;
Koch, LG ;
Britton, SL .
SCIENCE, 2005, 307 (5708) :418-420
[78]   Drug therapy: Thiazolidinediones [J].
Yki-Jarvinen, H .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (11) :1106-1118
[79]   The PROactive study:: some answers, many questions [J].
Yki-Järvinen, H .
LANCET, 2005, 366 (9493) :1241-1242
[80]   Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKKβ [J].
Yuan, MS ;
Konstantopoulos, N ;
Lee, JS ;
Hansen, L ;
Li, ZW ;
Karin, M ;
Shoelson, SE .
SCIENCE, 2001, 293 (5535) :1673-1677